Thermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $2.12, $0.01 better than the analyst estimate of $2.11. Revenue for the quarter came in at $4.65 billion versus the consensus estimate of $4.55 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.